Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for treatment of cancer, comprising an immune checkpoint inhibitor antibody and a fusion protein comprising an IL-2 mutant and a CD80 extracellular domain

Pharmaceutical composition for treatment of cancer, comprising an immune checkpoint inhibitor antibody and a fusion protein comprising an IL-2 mutant and a CD80 extracellular domain

US Patent 11639383 · Granted May 2, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition for enhancing radiotherapy comprising fusion protein 2025
Pharmaceutical composition for enhancing radiotherapy comprising fusion protein 2025
Fusion protein comprising anti-CD73 antibody and IL-2, and use thereof2025
Polypeptide dimer with high sialic acid content, comprising extracellular domain2025
Composition for culturing natural killer cells and method for preparing natural 2025
Composition comprising probiotics and polypeptide having binding affinity for Ig2024
Pharmaceutical composition for cancer treatment comprising fusion protein includ2024
Pharmaceutical composition for cancer treatment comprising fusion protein includ2024
Composition for culturing regulatory T cells and use thereof2023
Antibody against human DLK1 and use thereof2022
Antibody to programmed cell death 1 (PD-1) and use thereof2022
Wrist-type body composition measuring apparatus2021